1-2 of 2
Silvia Trappolini
Close
Sort by
Journal Articles

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial

Clinical Trials & Observations
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Francesca Paoloni, Monica Messina, Loredana Elia, Maria Stefania De Propris, Anna Maria Scattolin, Ernesta Audisio, Laura Marbello, Erika Borlenghi, Patrizia Zappasodi, Elisa Mauro, Giovanni Martinelli, Daniele Mattei, Nicola Fracchiolla, Monica Bocchia, Paolo De Fabritiis, Massimiliano Bonifacio, Anna Candoni, Vincenzo Cassibba, Paolo Di Bartolomeo, Giancarlo Latte, Silvia Trappolini, Anna Guarini, Antonella Vitale, Paola Fazi, Alfonso Piciocchi, Alessandro Rambaldi, Robin Foà
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4448–4461.
https://doi.org/10.1182/bloodadvances.2022009596
Published: 2023
Includes: Supplemental data
Journal Articles

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph + acute lymphoblastic leukemia

Clinical Trials & Observations
Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. Lemoli, Fabio Guolo, Antonella Fornaro, Monia Lunghi, Paolo de Fabritiis, Anna Candoni, Carmine Selleri, Federico Simonetti, Monica Bocchia, Antonella Vitale, Luca Frison, Alessandra Tedeschi, Antonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’Ardia, Silvia Trappolini, Patrizia Tosi, Piero Galieni, Francesco Fabbiano, Maria Chiara Abbenante, Muriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara Sartor, Stefania Paolini, Michele Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Michele Baccarani
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1742–1753.
https://doi.org/10.1182/bloodadvances.2021004821
Published: 2022